JAMES HEALY - Director at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
RAPP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by JAMES HEALY since 10 Feb 2025

Holdings reported by JAMES HEALY for Rapport Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,863,327 $18,596,003 $9.98 01 Jul 2024 By Sofinnova Venture Partners XI, L.P.
Common Stock 40,851 $407,693 $9.98 01 Jul 2024 By Crestline Summit Master, SPC - PEAK SP
Common Stock 39,661 $395,817 $9.98 01 Jul 2024 By CRESTLINE SUMMIT PINNACLE MASTER, L.P.
Common Stock 33,114 $330,478 $9.98 01 Jul 2024 By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP
Common Stock 18,641 $186,037 $9.98 01 Jul 2024 By Sofinnova Synergy Master Fund LP
Stock Option (Right to Buy) 21,850 17 Jun 2025 Direct Common Stock

Transactions reported by JAMES HEALY for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.